Records containing: Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-02A First-in-human, Phase I, Multi-center, Open-label, Dose-escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Evidence of Antitumor Activity of IDOV-Immune in Adult Participants With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-03-02An Open-label Phase 1/2 Dose Finding, Safety and Efficacy Study of Oral NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Uncontrolled Brain Metastasis in Patients With Select Solid Tumors.
-
CLINICAL_TRIALS study record update · 2026-03-02Phase I Study of Escalating Doses of XL888 With Vemurafenib Plus Cobimetinib for Patients With Unresectable BRAF Mutated Stage III/IV Melanoma
-
CLINICAL_TRIALS study record update · 2026-02-27Influence of a High-fiber Diet on the Microbiota and the Response to Immunotherapy in Patients Treated for Melanoma.
-
CLINICAL_TRIALS study record update · 2026-02-27Phase 1 Study of Trametinib + Ceritinib in Patients With Unresectable Melanoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-02-27PRIME-LRT: PRomoting IMmunotherapy Efficacy With Low-Dose Liver RT
-
CLINICAL_TRIALS study record update · 2026-02-27Molecular Profiling and Matched Targeted Therapy for Patients With Unresectable Advanced or Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2026-02-25Benefits of Lavender Essential Oil Aromatherapy in the Management of Preoperative Anxiety in Patients Undergoing Surgical Excision of Melanoma or Epithelioma: A Prospective Randomized Study
-
CLINICAL_TRIALS study record update · 2026-02-25Video Education With Result Dependent dIsclosure
-
CLINICAL_TRIALS study record update · 2026-02-24A Phase 1/2 Study of Tegavivint (NSC#826393) in Children, Adolescents, and Young Adults With Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
-
CLINICAL_TRIALS study record update · 2026-02-24A Randomized, Double-blind, Parallel-group Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of JPB898 (Proposed Nivolumab Biosimilar) and US-licensed and EU-authorized Opdivo® in Combination With Yervoy® in Participants With Untreated Advanced (Unresectable/Metastatic) Melanoma
-
CLINICAL_TRIALS study record update · 2026-02-24Preventing Lymphedema in Patients Undergoing Axillary Lymph Node Dissection Via Axillary Reverse Mapping and Lympho-venous Bypass
-
CLINICAL_TRIALS study record update · 2026-02-24Significance of Detection and Quantification of Circulating Tumor DNA in the Treatment of Melanoma Patients
-
CLINICAL_TRIALS study record update · 2026-02-23A Digital Intervention to Improve Skin Self-examination Among Melanoma Survivors
-
CLINICAL_TRIALS study record update · 2026-02-20The Florida Partnership for Adding Social Context to Address Cancer Survivorship Outcomes (Florida ASCENT)
-
CLINICAL_TRIALS study record update · 2026-02-20A Study of Dapansutrile Plus Pembrolizumab in Patients With PD-1 Refractory Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2026-02-20Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-02-19A Phase 3 Study of Fixed Dose Combinations of Fianlimab and Cemiplimab Versus Relatlimab and Nivolumab in Participants With Unresectable or Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2026-02-19Effectiveness and Safety of Dabrafenib in Combination With Trametinib as Adjuvant Treatment for Chinese Patients With Stage III BRAF V600 Mutation-positive Melanoma After Complete Resection
-
CLINICAL_TRIALS study record update · 2026-02-19A Feasibility Study of Multispectral Optoacoustic Tomography (MSOT) Imaging in Patients With Tumors
-
CLINICAL_TRIALS study record update · 2026-02-18A Phase 1/2 Study of KSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 Gene, in Patients With Select Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-02-18Phase 1/2a Open-Label, Dose-Escalation, Multicenter, FIH, Consecutive-Cohort, Clinical Trial of BI-1808, a Monoclonal Antibody to TNFR 2 as a Single Agent and in Combination With Pembrolizumab (MK-3475-D20) in Subjects With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2026-02-17INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)
-
CLINICAL_TRIALS study record update · 2026-02-17Analysis of the Tumor Microenvironment and Immune Response in Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2026-02-17Efficacy of Immunotherapy in the First Line of Treatment of Diffuse Melanoma in Slovenia and Recognition of Prognostic and Predictive Biomarkers From Primary Tumor, Faeces and Body Fluids